相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Appendectomy correlates with increased risk of pyogenic liver abscess: A population-based cohort study in Taiwan
Kuan-Fu Liao et al.
MEDICINE (2016)
Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery
Martin I. de Bock et al.
DIABETES CARE (2015)
Impact of Asthma on the Development of Coronary Vasospastic Angina A Population-Based Cohort Study
Ming-Jui Hung et al.
MEDICINE (2015)
Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
Shang-Hung Chang et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Rosiglitazone Attenuates Atrial Structural Remodeling and Atrial Fibrillation Promotion in Alloxan-Induced Diabetic Rabbits
Tong Liu et al.
CARDIOVASCULAR THERAPEUTICS (2014)
The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats
Zenat K. Salman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Metformin Attenuates the Exacerbation of the Allergic Eosinophilic Inflammation in High Fat-Diet-Induced Obesity in Mice
Marina Ciarallo Calixto et al.
PLOS ONE (2013)
Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study)
Joao D. Fontes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries, 1993-2007
Jonathan P. Piccini et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
Rachel R. Huxley et al.
HEART (2012)
Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes
Tze-Fan Chao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women
Tobias Schoen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
Evren Fidan et al.
ACTA DIABETOLOGICA (2011)
Meta-Analysis of Cohort and Case-Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation
Rachel R. Huxley et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes
Yung-Hsin Yeh et al.
CARDIOVASCULAR RESEARCH (2011)
Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus
Jun Gu et al.
EUROPACE (2011)
Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats
Osamu Kume et al.
HEART RHYTHM (2011)
Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation
David Conen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Recent advances in the molecular pathophysiology of atrial fibrillation
Reza Wakili et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal
Ulrich Schotten et al.
PHYSIOLOGICAL REVIEWS (2011)
Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation
Sascha Dublin et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation The WHS (Women's Health Study)
Usha B. Tedrow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
David Conen et al.
CIRCULATION (2009)
Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Gregory A. Nichols et al.
DIABETES CARE (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy
Panagiotis Korantzopoulos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
The potential role of thiazolidinediones in atrial fibrillation
Tong Liu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Thiazolidinedione use and postoperative atrial fibrillation: a US nested case-control study
Moise W. Anglade et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Mortality trends in patients diagnosed with first atrial fibrillation - A 21-year community-based study
Yoko Miyasaka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity
S Giannini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Epidemiology and natural history of atrial fibrillation: Clinical implications
SS Chugh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
分享论文
